During the past decade, Kaiser Permanente conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 11 clinical trials were completed, i.e. on average, 220% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "Seagen Inc." with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Dendreon" with 2 trials sponsored and "SWOG Cancer Research Network" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente" #1 collaborator was "National Cancer Institute (NCI)" with 6 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente" are "Breast Cancer" (2 trials), "Non Small Cell Lung Cancer" (2 trials), "Prostate Cancer" (2 trials), "Adenocarcinoma of the Colon" (1 trials) and "Adenocarcinoma of the Rectum" (1 trials). Many other conditions were trialed in "Kaiser Permanente" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente" are "Drug" (22 trials), "Biological" (8 trials), "Other" (6 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (6 trials), "Carboplatin" (5 trials), "Laboratory Biomarker Analysis" (4 trials), "Docetaxel" (3 trials) and "Placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente" are 20 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Permanente". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Kaiser Permanente, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Kaiser Permanente has several departments that took part in Clinical trials: "Kaiser Permanente Oncology/Hematology" - 5 trials, "Kaiser Permanente Northwest Region Oncology Hematology" - 5 trials